These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15741191

  • 1. Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis.
    Simonini G, Giani T, Stagi S, de Martino M, Falcini F.
    Rheumatology (Oxford); 2005 Jun; 44(6):777-80. PubMed ID: 15741191
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.
    JAMA; 2011 Dec 07; 306(21):2340-7. PubMed ID: 22056397
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.
    Arthritis Rheumatol; 2015 May 07; 67(8):2240-9. PubMed ID: 25891010
    [Abstract] [Full Text] [Related]

  • 4. Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study.
    Falcini F, Bindi G, Simonini G, Stagi S, Galluzzi F, Masi L, Cimaz R.
    J Rheumatol; 2003 Jan 07; 30(1):179-84. PubMed ID: 12508409
    [Abstract] [Full Text] [Related]

  • 5. Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
    Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G.
    Arthritis Care Res (Hoboken); 2014 Feb 07; 66(2):253-62. PubMed ID: 23983081
    [Abstract] [Full Text] [Related]

  • 6. Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
    Kearsley-Fleet L, Hyrich KL, Davies R, Lunt M, Southwood TR, British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
    Rheumatology (Oxford); 2015 Jul 07; 54(7):1279-85. PubMed ID: 25638806
    [Abstract] [Full Text] [Related]

  • 7. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
    Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Kurosawa R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS.
    Mod Rheumatol; 2011 Dec 07; 21(6):572-8. PubMed ID: 21479889
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Higuchi R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS.
    Mod Rheumatol; 2012 Sep 07; 22(5):720-6. PubMed ID: 22212889
    [Abstract] [Full Text] [Related]

  • 9. Quantitative ultrasonometry of the calcaneus in children with juvenile idiopathic arthritis.
    Kutilek S, Bayer M, Dolezalova P, Nemcova D.
    Rheumatology (Oxford); 2006 Oct 07; 45(10):1273-5. PubMed ID: 16595521
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.
    Arthritis Rheum; 2003 Apr 07; 48(4):1093-101. PubMed ID: 12687553
    [Abstract] [Full Text] [Related]

  • 11. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
    Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, Cate RT, Koopman-Keemink Y, van Santen-Hoeufft M, Raat H, van Suijlekom-Smit LW.
    Ann Rheum Dis; 2010 Jan 07; 69(1):138-42. PubMed ID: 19581280
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW.
    Ann Rheum Dis; 2009 May 07; 68(5):635-41. PubMed ID: 18413443
    [Abstract] [Full Text] [Related]

  • 13. Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment.
    Yeh KW, Lee CM, Chang CJ, Lin YJ, Huang JL.
    PLoS One; 2014 May 07; 9(6):e90757. PubMed ID: 24603504
    [Abstract] [Full Text] [Related]

  • 14. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.
    Tynjälä P, Lahdenne P, Vähäsalo P, Kautiainen H, Honkanen V.
    Ann Rheum Dis; 2006 Aug 07; 65(8):1044-9. PubMed ID: 16449314
    [Abstract] [Full Text] [Related]

  • 15. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
    Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ, Childhood Arthritis and Rheumatology Research Alliance (CARRA).
    J Rheumatol; 2014 Jun 07; 41(6):1163-70. PubMed ID: 24786928
    [Abstract] [Full Text] [Related]

  • 16. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM, Laxer RM, Babyn PS, Doria AS.
    J Rheumatol; 2006 Jun 07; 33(6):1186-8. PubMed ID: 16755667
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis].
    de Inocencio Arocena J, Merino Muñoz R, Alvarez Madrid C, García-Consuegra Molina J.
    An Pediatr (Barc); 2009 Apr 07; 70(4):354-61. PubMed ID: 19324597
    [Abstract] [Full Text] [Related]

  • 18. Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.
    De Sanctis S, Marcovecchio ML, Gaspari S, Del Torto M, Mohn A, Chiarelli F, Breda L.
    J Rheumatol; 2013 Jun 07; 40(6):943-8. PubMed ID: 23547210
    [Abstract] [Full Text] [Related]

  • 19. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y, Imanaka H, Nonaka Y, Takei S.
    Mod Rheumatol; 2007 Jun 07; 17(6):526-8. PubMed ID: 18084710
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis.
    Kuemmerle-Deschner JB, Horneff G.
    Rheumatol Int; 2007 Dec 07; 28(2):153-6. PubMed ID: 17641897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.